Table 2.
The top 10 productive journals in melanoma immunotherapy between 2010 and 2022.
| Journals with most papers | Paper number | Total citation | Citation per paper | Citation per paper per year a | H-index | G-index | IF (2020) |
|---|---|---|---|---|---|---|---|
| J. Immunother. Cancer | 133 | 3038 | 22.8 | 6.5 | 28 | 50 | 13.75 |
| Melanoma Res. | 95 | 1831 | 19.3 | 3.7 | 24 | 39 | 3.60 |
| Clin. Cancer Res. | 80 | 8753 | 109.4 | 17.5 | 43 | 78 | 12.53 |
| Cancer Immunol. Immunother. | 71 | 2145 | 30.2 | 5.6 | 25 | 45 | 6.97 |
| Cancers | 65 | 1891 | 29. 1 | 2.7 | 26 | 14 | 6.64 |
| OncoImmunology | 62 | 3149 | 50.8 | 7 | 28 | 42 | 8.11 |
| J. Immunother. | 52 | 294 | 5.7 | 4.4 | 10 | 37 | 4.46 |
| Eur. J. Cancer | 50 | 1489 | 29. 8 | 7 | 23 | 38 | 9.16 |
| Cancer Immunol. Res. | 47 | 1455 | 31.0 | 11.5 | 23 | 47 | 11.15 |
| J. Clin. Oncol. | 40 | 7709 | 192.7 | 34.2 | 30 | 40 | 44.54 |
a
Papers published in 2022 were not included for calculating citation per paper per year.